Laboratory diagnostics

Raising awareness of a silent crisis

Non-alcoholic fatty liver disease is increasingly common, but reversible.

5 min
Sameh Fahmy
Published on July 22, 2022

Like many patients, Tony Villiotti had never heard of non-alcoholic fatty liver disease (NAFLD) when his doctor first told him about this increasingly common condition. But  after his condition slowly and silently worsened, resulting in liver cancer and finally a liver transplant, he founded a non-profit organization to raise awareness of how early diagnosis and intervention can prevent devastating consequences.

“Early detection is invaluable,” Villiotti says. “That’s the single biggest thing a patient can do. If you’re aware of it early, you can take action early and hopefully stop the progression.” 


By Sameh Fahmy
Sameh Fahmy, MS, is an award-winning freelance medical and technology journalist based in Athens, Georgia, USA.